IQVIA Holdings | IQV - Betriebsaufwand





Betriebsaufwand Veränderung Datum
Accenture USD 15.82B 272.85M 2026-06
Agilent USD 1.43B 2M 2026-06
Bruker USD 790.5M 21.6M 2026-09
Cardinal Health USD -3.03B 65.88B 2026-09
Celltrion KRW 133.99B 14.77B 2026-06
Charles River Laboratories USD 3.23B 387.38M 2026-09
Cigna USD 43.38B 763M 2026-09
Cognizant Technology Solutions USD 14.73B 10.12B 2026-09
Cspc Pharmaceutical CNY 5.91B 512.77M 2025-12
CVS Health USD 104.83B 5.47B 2026-09
Danaher USD 53.62B 1.04B 2026-09
Dentsply International USD 1.36B 4M 2026-09
Deva Holding AS TRY 1.35B 178.26M 2023-09
Dianthus Therapeutics USD 62.24M 15.25M 2026-06
Divis Laboratories Ltd INR 22.52B 3.01B 2026-09
Elevance Health USD 49.28B 4.39B 2026-09
Humana USD 18.83B 20.68B 2026-09
IBM USD 14.63B 87M 2026-09
Illumina USD 525M 374M 2026-09
Infosys INR 388.5B 388.32B 2026-09
Kangmei Pharma CNY 1.22B 130.32M 2026-06
Knight Therapeutics CAD 126.9M 8.29M 2025-12
Laboratorios Farma EUR 313.62M 17.98M 2023-12
Laboratory Of America USD 3.39B 117.6M 2026-09
Malin Corporation EUR 1.1M 400K 2024-12
McKesson USD 109.27B 5.31B 2026-09
Mettler Toledo International USD 77.66M 662.11M 2026-09
Organigram Holdings CAD 100.45M 30.86M 2026-06
Ovoca Bio EUR 173K 990K 2025-12
Pharma Mar EUR 46.77M 4.24M 2026-09
Publicis EUR 7.58B 51M 2026-06
Qiagen NV USD 393.64M 17.95M 2026-06
Quest Diagnostics USD 2.62B 34M 2026-09
Revvity USD 604.27M 719K 2026-09
Sartorius EUR 746.5M 1.3M 2026-09
Sino Biopharmaceutical CNY 12.39B 1.26B 2025-06
Thermo Fisher Scientific USD 9.68B 134M 2026-09
Tilray USD 237.52M 17.34M 2025-09
UnitedHealth USD 106.35B 2.31B 2026-09
Veeva Systems USD 652.94M 43.11M 2026-06
Veradigm USD 188M 61.08M 2022-12
Waters USD 527M 592M 2026-06
Zealand Pharma A/S 573M 202.97M 2026-03
Zz Pientze Pharmaceu CNY 1.54B 90.74M 2026-09